Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gait Speed at Discharge as a Marker for Readmission - The GASP Study

NCT03049865 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT03049865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03049865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gait Speed at Discharge as a Marker for Readmission - The GASP Study
Lead sponsor
Karolinska University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
February 9, 2017
Completion date
December 31, 2027
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

all disease that may require acute hospitalization except for phsychiatric disease